IRIS Accounts Production v24.1.0.578 12823661 director 1.4.23 31.3.24 31.3.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128236612023-03-31128236612024-03-31128236612023-04-012024-03-31128236612022-03-31128236612022-04-012023-03-31128236612023-03-3112823661ns15:EnglandWales2023-04-012024-03-3112823661ns14:PoundSterling2023-04-012024-03-3112823661ns10:Director12023-04-012024-03-3112823661ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112823661ns10:SmallEntities2023-04-012024-03-3112823661ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112823661ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3112823661ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112823661ns10:FullAccounts2023-04-012024-03-3112823661ns10:RegisteredOffice2023-04-012024-03-3112823661ns5:CurrentFinancialInstruments2024-03-3112823661ns5:CurrentFinancialInstruments2023-03-3112823661ns5:ShareCapital2024-03-3112823661ns5:ShareCapital2023-03-3112823661ns5:SharePremium2024-03-3112823661ns5:SharePremium2023-03-3112823661ns5:RetainedEarningsAccumulatedLosses2024-03-3112823661ns5:RetainedEarningsAccumulatedLosses2023-03-3112823661ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3112823661ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 12823661 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31 March 2024

for

REMEDIUM CAPITAL LIMITED

REMEDIUM CAPITAL LIMITED (REGISTERED NUMBER: 12823661)






Contents of the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


REMEDIUM CAPITAL LIMITED

Company Information
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTOR: D Hawkins





REGISTERED OFFICE: 43 Crescent West
Barnet
EN4 0EQ





REGISTERED NUMBER: 12823661 (England and Wales)





ACCOUNTANTS: Marchant Lewis Limited
105a Caversham Avenue
London
N13 4LL

REMEDIUM CAPITAL LIMITED (REGISTERED NUMBER: 12823661)

Balance Sheet
31 MARCH 2024

31.3.24 31.3.23
Notes £    £   
CURRENT ASSETS
Debtors 4 54,101 109
Cash at bank 34,821 154,571
88,922 154,680
CREDITORS
Amounts falling due within one year 5 12,222 552
NET CURRENT ASSETS 76,700 154,128
TOTAL ASSETS LESS CURRENT
LIABILITIES

76,700

154,128

CAPITAL AND RESERVES
Called up share capital 2,147 2,081
Share premium 750,494 671,360
Retained earnings (675,941 ) (519,313 )
SHAREHOLDERS' FUNDS 76,700 154,128

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 May 2024 and were signed by:





D Hawkins - Director


REMEDIUM CAPITAL LIMITED (REGISTERED NUMBER: 12823661)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Remedium Capital limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 20,000 -
Other debtors 34,101 109
54,101 109

REMEDIUM CAPITAL LIMITED (REGISTERED NUMBER: 12823661)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2024

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors 197 2
Tax 11,475 -
Accrued expenses 550 550
12,222 552